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yet been fully met in Belgium. Despite the success of the policy, adjustments are
desirable, especially with respect to the broad definition of cheap medicines. Given
the fact that all groups of physicians reached their minimum quota quite easily
together with the increased possibility of prescribing cheap medicines due to the
entrance of new, generic medicines, the government decided to raise the minimum
criteria in 2011.
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OBJECTIVES: To analyze state funding sources of drug provision all over RF for the
period of 2009-2010. METHODS: Different sources of drug funds were summed up
during this research. All materials were taken from the open sources: results of
auctions of the federal and regional level, orders of the Ministry of Public Health
and Social Development, analysis of regional programs of the drug provision and
etc. RESULTS: Interactive map of the RF was developed due to this analysis of the
collected data, it shows information on each region of the RF, the number of priv-
ileges people, population of the region, sum of the budget by the ONLS (reimburse-
ment) programs, the sum of the budget according to the regional reimbursement,
sum of the hospital budgets, sum of the special programs of the region (if such
programs approved in the region), sum of the budget by the program “7 nosologies”
(special reimbursement program), with the detailed separation of the budget ac-
cording to the nosologies. Such map clearly demonstrates difference in the funding
system between regions. The ranges of color distinction by regions were put into
the map for more convenient usage, it allows visually demonstrate difference in
funding on the territory of the RF. Several pilot regions of the RF were chosen where
data was validated, this process showed complete conformity of the existing data
with the official budgets of the regions. CONCLUSIONS: Nowadays this research
represents unique product in acceptance of administrative decisions for the ad-
ministrators of health sector of the RF. Also for the further improvement of the
given analytical system it is necessary to adjust the collecting of the corresponding
data for 2011 and to analyze the budget of regions on the Federal Health Modern-
ization Program 2011-2012.
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OBJECTIVES:General public perceptions will affect on their behavior towards med-
icines. Therefore, this study aims to evaluate the general public perceptions to-
wards medicines in the state of Penang Malaysia. METHODS: A cross sectional
study using convenience sampling technique was used. Appropriate descriptive
and inferential statistics were used to find the differences among the respondents.
All data were analyzed at alpha value of 0.05. RESULTS: Seven hundred respon-
dents were successfully responded to the survey. More than one third of the re-
spondents 37% stated that they understand what is meant by conventional medi-
cines, whereas 18.6% understand traditional medicines and only 3% understand
what is meant by generic medicines. On the other hand, 36% see doctor once they
have minor illness and 30% prefer to go to get OTC drugs from the community
pharmacy. Furthermore, 62% believe that more expensive drugs are of better qual-
ity, and more than 50% believe that advertising affect on their perceived quality of
medicines as well as the country of the manufacturer affects on their selection of
the drugs. Previous experience, physician’s recommendations, pharmacist’s rec-
ommendations, friend’s recommendations, cost of the medicine and medical in-
surance coverage were the main factors that affect on their perceptions.
CONCLUSIONS: General public in Penang are very concerning about the medicine
chosen. General public education on various types of medicines is important to
correct misconceptions and give them the knowledge that they need to make an
informed decision. Hence, physicians, pharmacists and other health care providers
play vital roles in educating the general public about medicines.
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OBJECTIVES: Disease related malnutrition (DRM) is a frequent but often unrecog-
nised problem, even in the developed world. The objective of this study was to
estimate the burden of disease related malnutrition (BoDRM) in Europe.METHODS:
An Excel model was developed to estimate direct incremental health care costs and
health burden (including increased mortality and reduced quality of life) due to
DRM. The monetary value of the health burden was calculated by multiplying the
QALY loss with explicit or implicit (2x GDP/capita) cost effectiveness thresholds in
each country. Collection of input variables involved a wide spectrum of current
data sources: international databases, PubMed, congress abstracts, references
from published papers. Ten primary diseases were incorporated into the model:
stroke, breast cancer, COPD, dementia, depression, colorectal cancer, musculosk-
eletal disorders, head and neck cancer, coronary heart disease, chronic
pancreatitis. RESULTS: For the 835 million European citizens, the direct financial
BoDRM is over 31 billion EUR annually. The estimated annual health burden is
approximately 5.7 million life years or 9.1 million QALYs. The total monetary value
of the health and financial BoDRM is 306 billion EUR. The health burden in chronic
diseases is greater than in acute diseases, and is also greater than the financial
burden. In acute diseases, the financial burden is greater than the health burden.
CONCLUSIONS: In Europe, DRM is a considerable health and financial burden and
represents a significant contribution to the total burden of disease, estimated by
WHO to be 255 million DALYs annually. Therefore, there is a need to improve
nutritional care in all aspects of patient management. The availability of scientific
data on DRM is limited, especially regarding the relative mortality risk and quality
of life impact. Policy makers should support programmes to extend the clinical and
economic evidence base for nutritional care.
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OBJECTIVES:The inclusion of lost productivity costs in pharmacoeconomic studies
is still a subject of considerable debate. The aim of this study was to quantify the
work impairment due to general health status in population of employees and
employers (i.e. owners and managers). METHODS: Data were obtained from a sur-
vey that incorporated the WPAI-GH questionnaire and questions on costs of worker
replacement (including hiring and training process). The survey was conducted in
cooperation with Employers of Poland – the largest and oldest organisation of
employers in Poland in the framework of research grant no N N405 115034 offered
by the Ministry of Science and Higher Education of the Republic of Poland.
RESULTS: The non-representative population comprised 196 subjects in paid jobs
(156 employees and 40 employers), 167 of whom were currently employed in gov-
ernment-owned corporations (with 250 employees). Employees reported 7.4% of
work time missed due to health problems (absenteeism) during the past 7 days
(0.8% for employers; p0.052). Impairment while being at work (presenteeism)
amounted to 12.2% of total time for employers (5.4% for employers; p0,05). Per-
centage of overall work impairment due to health problems for employees and
employers were 5.7% vs. 18.3%, respectively (p0.05). On average more than 50% of
overall work impairment was compensated by other employees in the company
with a general tendency of a higher compensation of employees’ responsibilities.
Mean time of hiring and training new worker to achieve 50% of expected produc-
tivity was 76 days and 216 days to achieve full productivity. CONCLUSIONS: Pro-
ductivity loss measured by WPAI-GH is higher among employees than employers
in analyzed sample in Poland, with a tendency of a higher compensation among
employees. Preliminary data suggest that overall work impairment can be com-
pletely compensated within a one year from a single employer perspective and
support friction cost approach.
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OBJECTIVES: An automated dose dispensing (ADD) service is implemented in pri-
mary health care in some countries, particularly in the Nordic countries. In this
service, regularly used medicines are machine-packed into unit-dose bags for each
point of administration. The aim of this study is to review the evidence of the ADD’s
influence on the appropriateness of medication use, medication safety and costs in
the primary health care.METHODS:A literature search was performed on the most
relevant databases, including the Medline, Embase, and Cochrane Library. An ar-
ticle was included in the review if the study was conducted in primary health care
or nursing home settings and medicines were dispensed in unit-dose bags. All
study designs were approved and control groups were not required. Studies apply-
ing outcome measures that were related to the appropriateness of medication use,
medication safety or costs were included. RESULTS: Out of 278 abstracts, six stud-
ies were found to be acceptable. The prevalencies of potential inappropriate drug
use (IDU) were higher among ADD users than non-ADD users. After controlling for
confounding factors, ADD reduced the probability of long-acting benzodiazepine
use among women and drug-drug interactions among women and men. The ADD
users aged 65-79 years had more problems with potential IDU than older ones
(80 years). The risk of administration errors was lower if medicines were supplied
by the ADD service. The ADD service also reduced discrepancies in the documen-
tation of patient medication records. Any costs were not investigated in the
studies. CONCLUSIONS: The evidence of the influence of ADD on appropriateness
of medication use and medication safety is limited, and missing on costs. The
findings of this review suggest that the ADD service may improve medication
safety in primary health care, but does not effectively reduce potential IDU.
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OBJECTIVES: To evaluate the feasibility of the C.A.T-Health system (a computer-
ized adaptive test which evaluates generic Health-Related Quality of Life-HRQoL) in
a university hospital, at different levels of the health care process. METHODS: The
C.A.T-Health system has been developed and validated within a 3 years research
A348 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 2 3 3 - A 5 1 0
project. The system is implemented in software to fill in the test through a touch
screen. According to Item-Response Theory, items showed to the respondent are
selected from a pool of items based on the answers to the previous questions. The
test can vary from 5 to 15 questions. The C.A.T-Health system was installed during
1 week at 3 locations at the Hospital Central de Asturias: Hemodialysis Unit (HDU),
Nephrology Hospitalization Unit (NHU) and Nephrology Outpatient Consultancy
(NOC). Patients visiting each of these locations were allowed to answer the ques-
tionnaire, though they were not asked to do it. The sanitary staff and the patients’
relatives were also allowed to answer the test. The percentage of patients who
started and finished answering the C.A.T-Health system, the time of completion
and the number of items showed were collected. RESULTS: 597 subjects started
answering the C.A.T-Health system. 366 subjects (61.31%) completed the test: 96
patients, 180 sanitary staff and 80 patients’ relatives. The percentage of patients
who spontaneously answered the test was 64% and 55%, with respect to the total
number of patients visiting HDU and NHU, respectively. The median number of
items was 10 (HDU), 9 (NHU) and 8 (NOC). The median time of completion was 118.5
(HDU), 124.9 (NHU) and 113.13 seconds (NOC). The worst C.A.T-Health mean score
was that of patients visiting HDU. CONCLUSIONS: The C.A.T-Health system is a
feasible innovative HRQoL questionnaire which allows the use of patients’ per-
ceived health as an outcome variable in the evaluation of the health care process.
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OBJECTIVES: Patient-centered care, in which health services are customized on the
basis of patients’ needs and values, is seen as a critical factor in a high-performance
health care system. This project seeks to characterize patients’ needs and values
for specific features of health care delivery systems. METHODS: Quantitative data
were obtained by means of a discrete choice experiment (DCE). Alternatives were
described by specific attributes that described certain features of a health care
delivery system. Each set included six attributes with three specific levels. The DCE
was divided into four blocks based on thematic mapping (DCE 1, patient involve-
ment; DCE 2, point of care; DCE 3, personnel; DCE 4, organization). RESULTS: In
preliminary results, N663 respondents have completed the survey so far. The
feature “out-of-pocket costs” was the most important attribute across all 4 DCEs
(DCE 1 coefficient, 0.59025; DCE 2 coefficient, 1.20715; DCE 3 coefficient, 0.99938.
DCE 4 coefficient, 0.99079). In DCE 1 regarding patient involvement, “trust and
respect” (0.50411) and “attention to personal situation” (0.33664) were of greatest
importance. In DCE 2 addressing preferences at the point of care, “shared decision
making” (0.77153) and “access to patient record” (0.51370) were nearly equally valu-
able to patients but of highest relevance. In DCE 3 focusing on personnel in health
care delivery systems, “multidisciplinary care” (0.74468) was ranked highest.
Lastly, in DCE 4 analyzing features of the organization of health care delivery sys-
tems, “travel time” (0.39266), “medical devices and furnishings” (0.41689), and
“treatment guidelines” (0.41566) were of almost equal value to patients.
CONCLUSIONS: The study is intended to close the gap between simplistic repre-
sentations of patient preferences in today’s health care systems and the complex-
ity of actual patient decision-making processes by using the specification and ex-
planatory power of DCEs.
PHP88
SOCIETAL UNMET NEEDS WITHIN SPAIN
Dibonaventura MD1, Isherwood G2, Buenestado B3, Manso M3
1Kantar Health, New York, NY, USA, 2Kantar Health, Epsom, Surrey, UK, 3Kantar Health,
Madrid, Spain
OBJECTIVES: The aim of the current study is to examine how unmet needs, defined
as prevalence rates, treatment rates, and quality of life, compare between Spain
and other countries in the EU. METHODS: Data from the EU National Health and
Wellness Survey (NHWS) were used (N57,805), with respondents from France,
Germany, Italy, Spain, and UK (“5EU”). NHWS is an internet-based survey which
relies on a random stratified sampling framework to ensure demographic repre-
sentativeness of each country. Among the 10 most prevalent conditions in 5EU,
differences in prevalence, treatment rates, and health utilities (using the SF-6D)
were compared between 5EU and Spain (N5,039).RESULTS: Prevalence rates were
lower in Spain for 7 of the 10 conditions investigated. Despite the lower prevalence
rates, treatment rates for these conditions were consistently higher. The single
exception was dyslipidemia, which was more prevalent in Spain (24.2% vs. 14.7%)
and had a lower treatment rate (50.7% vs. 56.0%) than elsewhere in 5EU. Stronger
beliefs in seeing their physician and in prescription medications were also reported
by Spanish patients relative to elsewhere in 5EU. The greatest unmet needs in
Spain, defined as high prevalence estimates and low treatment rates and health
utilities, were reported for patients with insomnia/sleep difficulties (Preva-
lence27.6%, Treatment rate31.4%, Utilities0.67) and anxiety (Preva-
lence23.3%, Treatment rate41.2%, Utilities0.62). CONCLUSIONS: The results
suggest prevalence rates are generally lower in Spain than the rest of 5EU though
treatment rates are higher. The latter finding could be due to a greater belief in
regular contact with physicians and prescription medications in general. Never-
theless, several unmet needs exist for Spanish patients, particularly for insomnia/
sleep difficulties and anxiety.
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OBJECTIVES: Preventable adverse drug reactions (ADRs) are some of the most com-
mon consequences of medication errors (MEs). Database of ADR reports can pro-
vide information on wide range of different adverse events and other medication
related problems including MEs. The aim of this study was to identify MEs from
ADR reports in the Thai Food and Drug Administration (Thai FDA) database.
METHODS:ADR reports of Statin drugs in the Thai FDA database between 1993 and
2009 were retrospectively analyzed. Reports were assessed for identifying MEs
regarding type of MEs that caused ADR and the subsequent adverse outcome.
RESULTS: Of the 1682 reports assessed, 74 reports (4.40%) were identified as MEs
that caused ADR. Regarding the type of MEs, most of them were related to failure to
adjust for drug-drug interaction (86.5%) following by overdose (13.5%). Among 74
ADRs resulting from MEs, 49 (66%) were serious outcomes and 25 (34%) were con-
sidered as non serious outcomes. CONCLUSIONS: Analysis of ADR database iden-
tified circumstances that are most prone to errors. This capacity can contribute to
the detection and prevention of medication related problems, therefore enhance
patient safety.
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OBJECTIVES: In Italy the role of community pharmacies is changing. The reform
the country is undertaking aims at designing a community pharmacy delivering a
number of services and highly involved in the health system. Consequently, new
skills and knowledge are required for the pharmacists to be successful regard both
the health objectives and the economic ones. The aim of the paper is to analyze a)
the perceptions of the pharmacists toward the new context defined by the recent
reform, and b) their attitude to play the changing agent role. Thus, the ability of the
pharmacists to have a strategic orientation, the nature of its information system,
and the his/her knowledge of the context will be investigated.METHODS: A survey
has been designed, and a questionnaire submitted to a national sample of 500
community pharmacies. The questionnaire was organized in 4 sections: the gen-
eral profile and training; his/her perception of the role played; the strategic orien-
tation; the pharmacy information system. Answers were graded according to the
Likert scale 1-7. The response rate was 32%. RESULTS: Data highlight how the
pharmacies are already challenging the changing context offering a range of ser-
vices: prevention campaign (71,8%), booking diagnostic exams and specialists’ vis-
its (50,9%), participation to health education programs (49%). However, the strate-
gic attitude of respondents is not very high (m4.90). Pharmacies deliver a range of
services to improve customers fidelity, and their image toward the community. It
has not been detected a correlation between range of services delivered and profit
targets. Pharmacies have a good control of the global financial results, but a poor
ability to monitor partials results. CONCLUSIONS: Pharmacies know the new
model of pharmacy the government is introducing, however it doesn’t seem they
have the right background and attitudes to challenge the new context.
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OBJECTIVES:A business hours study by pharmacy practice was examined as a part
of patient safety activities associated with hospital pharmacy. METHODS: We sur-
veyed nationwide the situation of patient safety activities in hospitals allowed for
additional costs on patient safety measures under the social insurance medical fee
schedule. Of targeted 2674 hospitals (all hospitals: 8706 as of June 1) in Japan, 669
hospitals responded (response rate: 25.0%). Pharmacy practice includes medica-
tion teaching and history administration, brought drugs review on admission, drug
adjustment and dispense, question reference from out-of-hospital pharmacy, drug
information for safety use. RESULTS:We classified 669 hospitals into three classes;
additional cost I (85 points) implementing hospitals with more than 401 beds (A
group: 173 hospitals), additional cost I (85 points) implementing additional cost I
with less than 400 beds (B group: 306 hospitals), and additional cost II (35 points)
implementing hospitals (C group: 180 hospitals). The time spent for medication
teaching and history administration was 20.6% of all pharmacy practices in A
group, 20.4% in B group, and 18.1% in C group. Similarly, the time for brought drugs
review was 6.6% in A group, 8.2% in B, and 7.5% in C, and the time for drug adjust-
ment and dispense of anti-neoplastic drugs was 9.4% in A, 5.9% in B, and 1.9% in C.
The time for question reference from out-of-hospital pharmacy was 2.9% in A, 4.3%
in B, and 4.6% in C. CONCLUSIONS: The time for medication teaching and history
administration, and drug adjustment and dispense of neo-plastic drug and IVH
were spent much more time at large scale hospitals like A group hospitals than at
small scale hospitals like C group hospitals.
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OBJECTIVES: The objective of this study is to verify if the clinical efficacy is the
main reason on which negative recommendations issued by AHTAPol (Agency for
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